How are we changing clinical trials?
Summary of the EMA September 2022 Qualification Opinion for PROCOVA™
September 27, 2022
The European Medicines Agency has qualified Unlearn’s AI-powered method for running smaller, faster clinical trials.
Case study: TwinRCTs™ reduce control arm sizes for rare neurodegenerative diseases
How Digital Twin Technology is Disrupting Healthcare
Next-gen digital health innovation in clinical trials
December 8, 2020
The Rock Health team reflects on the evolution of digital in clinical trials, discuss the current state, and explore the opportunity to further transform drug discovery.
February 15, 2021
The use of digital twins in the healthcare industry is revolutionizing clinical processes.
July 13, 2022
Learn more about how TwinRCTs™ reduce control arm sizes by up to 22% for Phase 3 trials in HD and ALS.
December 13, 2021
Using AI-based Prognostic Models to Design Efficient, Unbiased Clinical Trials
December 3, 2020
The Bio Report Podcast: Using AI Created Digital Twins to Accelerate Clinical Trials
July 30, 2020
Saving Minds Podcast #27: Using Artificial Intelligence to speed Alzheimer’s studies
November 7, 2019
The FDA needs to set standards for using artificial intelligence in drug development
Applying Machine Learning to Increase Clinical Trial Efficiency: A Regulatory Journey
May 19, 2022
Learn about the evolution of ideas that led to our TwinRCT™ solution for smaller, more efficient clinical trials and recent EMA draft qualification opinion.
PROCOVA™ Handbook for the Target Trial Statistician
March 22, 2022
This handbook provides step-by-step guidance for the practical application of our PROCOVA™ procedure for Phase 2 or 3 TwinRCTs™.
Recruit Rockstars Podcast #367: How His VC-Backed Team Made Drug Development Faster
Will digital clones transform how pharmas run clinical trials? This S.F. startup is counting on it.
Generating Digital Control Subjects using Machine Learning for Alzheimer's Disease Clinical Trials (CTAD 2019)
December 6, 2019
The ability to reduce the burden on control subjects with subjects in clinical trials for complex diseases like Alzheimer’s Disease would drastically improve the search..
May 4, 2020
The San Francisco-based company creates digital replicas of participants in clinical drug trials using artificial intelligence.
November 15, 2020
Unlearn helps biopharma companies develop drugs more efficiently by leveraging AI to reduce the number of patients required for placebo controls in clinical trials.
Interested in a partnership?
© Unlearn.AI, Inc. All Rights Reserved
Work with us
We are here to answer your questions.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.